Last 12 months
Inside the activity.
1 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2020 Filed Jun 26, 2020 16:04 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001104659-20-077449 · a4.xml · derivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 16:02 UTC |
PEACOCK BRUCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001104659-20-077440 · a4.xml · derivative · entry 1 PEACOCK BRUCE · CIK 0001228459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:03 UTC |
Williams Leslie J.Director
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001104659-20-077446 · a4.xml · derivative · entry 1 Williams Leslie J. · CIK 0001770465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:04 UTC |
Hong Seung SuhDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001104659-20-077448 · a4.xml · derivative · entry 1 Hong Seung Suh · CIK 0001774271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 20:03 UTC |
Heier Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $8.75 | $0.00 |
DisclosureSEC source: 0001104659-20-077441 · a4.xml · derivative · entry 1 Heier Jeffrey S. · CIK 0001653082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-06-24 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:15 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 363,636 | $5.50 | $1,999,998.00 |
DisclosureSEC source: 0001567619-20-010898 · doc1.xml · nonDerivative · entry 1 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,618,424 F1 · shares: These shares of Common Stock, $0.0001 par value per share (the "Shares"), were purchased directly from the underwriters in an underwritten public offering conducted by the Issuer on May 19, 2020 (the "Offering"). Pursuant to the Offering, the Reporting Person agreed to purchase the Shares at a public offering price of $5.50 per share. The Issuer's Rule 424(b)(5) prospectus supplement (File No. 333-229085) in connection with the Offering was filed with the Securities and Exchange Commission (the "SEC") on May 20, 2020. F1 · price: These shares of Common Stock, $0.0001 par value per share (the "Shares"), were purchased directly from the underwriters in an underwritten public offering conducted by the Issuer on May 19, 2020 (the "Offering"). Pursuant to the Offering, the Reporting Person agreed to purchase the Shares at a public offering price of $5.50 per share. The Issuer's Rule 424(b)(5) prospectus supplement (File No. 333-229085) in connection with the Offering was filed with the Securities and Exchange Commission (the "SEC") on May 20, 2020. F2 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time. F3 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F2 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time. F3 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F2 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the SEC on March 4, 2019, as amended from time to time. F3 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 24, 2020 Filed Mar 25, 2020 01:42 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 35,052 | $4.87 | $170,713.76 |
DisclosureSEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 3 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,254,788 F5 · price: Represents the weighted average set forth in this line item. On March 24, 2020, the Reporting Person acquired 35,052 shares of Common Stock at a weighted average price of $4.8703 (ranging from a low of $4.59 and a high of $5.18). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 01:42 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 64,948 | $4.66 | $302,365.41 |
DisclosureSEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 2 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,219,736 F4 · price: Represents the weighted average set forth in this line item. On March 23, 2020, the Reporting Person acquired 64,948 shares of Common Stock at a weighted average price of $4.6555 (ranging from a low of $4.09 and a high of $4.94). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 01:42 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 9,100 | $4.52 | $41,119.26 |
DisclosureSEC source: 0001567619-20-006975 · doc1.xml · nonDerivative · entry 1 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,154,788 F3 · price: Represents the weighted average set forth in this line item. On March 20, 2020, the Reporting Person acquired 9,100 shares of Common Stock at a weighted average price of $4.5186 (ranging from a low of $4.15 and a high of $5.13). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 19, 2020 Filed Mar 21, 2020 01:34 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 40,900 | $4.63 | $189,223.85 |
DisclosureSEC source: 0001567619-20-006870 · doc1.xml · nonDerivative · entry 2 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,145,688 F4 · price: Represents the weighted average set forth in this line item. On March 19, 2020, the Reporting Person acquired 40,900 shares of Common Stock at a weighted average price of $4.6265 (ranging from a low of $4.40 and a high of $4.81). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 18, 2020 Filed Mar 21, 2020 01:34 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 344,938 | $4.62 | $1,594,199.95 |
DisclosureSEC source: 0001567619-20-006870 · doc1.xml · nonDerivative · entry 1 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 5,104,788 F3 · price: Represents the weighted average set forth in this line item. On March 18, 2020, the Reporting Person acquired 344,938 shares of Common Stock at a weighted average price of $4.6217 (ranging from a low of $4.14 and a high of $5.24). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 01:35 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 550,000 | $4.66 | $2,562,890.00 |
DisclosureSEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 3 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 4,759,850 F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:35 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 194,262 | $4.16 | $807,216.89 |
DisclosureSEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 2 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 4,209,850 F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:35 UTC |
Summer Road LLC10% owner
|
PurchaseCommon Stock, $0.0001 par value per share | 210,800 | $4.63 | $975,982.92 |
DisclosureSEC source: 0001567619-20-006639 · doc1.xml · nonDerivative · entry 1 SUMMER ROAD LLC · CIK 0001604873 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Client Disclosed balance after: 4,015,588 F3 · price: Represents the weighted averages set forth in this line item. On March 13, 2020, the Reporting Person acquired 210,800 shares of Common Stock at a weighted average price of $4.6299. On March 16, 2020, the Reporting Person acquired 194,262 shares of Common Stock at a weighted average price of $4.1553. On March 17, 2020, the Reporting Person acquired 550,000 shares of Common Stock at a weighted average price of $4.6598. Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price, and the range of prices for the transactions reported on this Form 4. F1 · balance_after: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · balance_after: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.direct: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.direct: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. F1 · ownership.nature: Reporting Person is a family office of the same family under Investment Advisers Act of 1940 Rule 202(a)(11)(G)-1 (the "Family Office Rule"). Pursuant to investment management agreements ("IMAs") between itself and its "Family Clients" (as defined in the Family Office Rule), Reporting Person exercises voting and dispositive power with respect to the Issuer's common stock, par value $0.0001 per share, held by each of the Family Clients. The Reporting Person also reports beneficial ownership pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, as amended, pursuant to a Schedule 13D previously filed with the Securities and Exchange Commission on March 4, 2019, as amended. F2 · ownership.nature: Represents securities beneficially owned by Reporting Person through an IMA entered into with a Family Client. The securities as to which this Form 4 is filed by Reporting Person are owned of record by Cap 1 LLC, a Family Client of Reporting Person ("Cap 1"). Cap 1 is wholly owned by Crystal Fiduciary Company, LLC, as Trustee of the AR Irrevocable Trust. Reporting Person has no pecuniary interest in the securities beneficially owned by the Family Clients of Reporting Person. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:28 UTC |
Mattessich Antony C.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001104659-20-009945 · a4.xml · derivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2030-01-29 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 18:27 UTC |
Goldstein Michael H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001104659-20-009939 · a4.xml · derivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2020-01-29 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:28 UTC |
Kitchen PatriciaChief Operations Officer
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001104659-20-009943 · a4.xml · derivative · entry 1 Kitchen Patricia · CIK 0001781346 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2030-01-29 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 30, 2020 Filed Feb 3, 2020 23:27 UTC |
Notman DonaldChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 215,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001104659-20-009941 · a4.xml · derivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires 2030-01-29 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 4, 2020 00:45 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.0001 per share | 15,000 | $3.90 | $58,507.50 |
DisclosureSEC source: 0001493152-20-000167 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 4,918,500 F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9005. The range of purchase prices on the transaction date was $3.895 to $3.94 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 22:15 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.0001 per share | 5,000 | $3.97 | $19,852.50 |
DisclosureSEC source: 0001493152-20-000059 · ownership.xml · nonDerivative · entry 2 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Account Disclosed balance after: 207,500 F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9705. The range of purchase prices on the transaction date was $3.93 to $3.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F3 · ownership.nature: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 22:15 UTC |
Opaleye Management Inc.10% owner
|
PurchaseCommon Stock, par value $0.0001 per share | 15,000 | $3.97 | $59,557.50 |
DisclosureSEC source: 0001493152-20-000059 · ownership.xml · nonDerivative · entry 1 Opaleye Management Inc. · CIK 0001595855 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Opaleye, L.P. Disclosed balance after: 4,903,500 F1 · price: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9705. The range of purchase prices on the transaction date was $3.93 to $3.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. F2 · ownership.nature: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. ("Opaleye") may be deemed to beneficially own the securities owned directly by the Fund. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:28 UTC |
Kitchen PatriciaChief Operations Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $4.62 | $0.00 |
DisclosureSEC source: 0001104659-19-039308 · a4.xml · derivative · entry 1 Kitchen Patricia · CIK 0001781346 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-06-30 F1 · derivative.exercise_date: Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and 2.0833% of the shares vesting monthly thereafter. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 23:21 UTC |
Notman DonaldChief Financial Officer
|
PurchaseCommon Stock | 2,500 | $4.33 | $10,825.00 |
DisclosureSEC source: 0001104659-19-036009 · a4.xml · nonDerivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,049 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.33, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · balance_after: Includes 4,249 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 23:21 UTC |
Williams Leslie J.Director
|
PurchaseCommon Stock | 4,500 | $4.40 | $19,800.00 |
DisclosureSEC source: 0001104659-19-036008 · a4.xml · nonDerivative · entry 1 Williams Leslie J. · CIK 0001770465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.32 to $4.44, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 17:18 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001104659-19-035410 · a4.xml · derivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 17:19 UTC |
PEACOCK BRUCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001104659-19-035412 · a4.xml · derivative · entry 1 PEACOCK BRUCE · CIK 0001228459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 17:20 UTC |
Warden Charles MDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001104659-19-035413 · a4.xml · derivative · entry 1 Warden Charles M · CIK 0001354802 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 21:20 UTC |
Hong Seung SuhDirector
|
GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001104659-19-035414 · a4.xml · derivative · entry 1 Hong Seung Suh · CIK 0001774271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 21:19 UTC |
Heier Jeffrey S.Director
|
GrantStock Option (Right to Buy) · Derivative | 18,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001104659-19-035411 · a4.xml · derivative · entry 1 Heier Jeffrey S. · CIK 0001653082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: Vests with respect to 100% of the securities on the first anniversary of the grant date. Read SEC document |
| June 07, 2019 Filed Jun 10, 2019 20:55 UTC |
Sawhney AmarpreetDirector · Chairman of the Board
|
PurchaseCommon Stock | 65,468 | $3.02 | $197,713.36 |
DisclosureSEC source: 0001104659-19-034633 · a4.xml · nonDerivative · entry 2 Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,056,031 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $3.20, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:53 UTC |
Mattessich Antony C.Director · President & CEO
|
PurchaseCommon Stock | 40,000 | $2.81 | $112,400.00 |
DisclosureSEC source: 0001104659-19-034632 · a4.xml · nonDerivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.79 to $2.82, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:55 UTC |
Sawhney AmarpreetDirector · Chairman of the Board
|
PurchaseCommon Stock | 59,000 | $2.80 | $165,200.00 |
DisclosureSEC source: 0001104659-19-034633 · a4.xml · nonDerivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990,563 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.73 to $2.88, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 05, 2019 Filed Jun 6, 2019 22:09 UTC |
Sawhney AmarpreetDirector · Chairman of the Board
|
PurchaseCommon Stock | 32,852 | $2.91 | $95,599.32 |
DisclosureSEC source: 0001104659-19-034353 · a4.xml · nonDerivative · entry 2 Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,563 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| June 04, 2019 Filed Jun 6, 2019 22:09 UTC |
Sawhney AmarpreetDirector · Chairman of the Board
|
PurchaseCommon Stock | 12,928 | $2.92 | $37,749.76 |
DisclosureSEC source: 0001104659-19-034353 · a4.xml · nonDerivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898,711 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.89 to $2.95, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 28, 2019 Filed May 30, 2019 16:10 UTC |
Goldstein Michael H.Chief Medical Officer
|
PurchaseCommon Stock | 12,000 | $2.51 | $30,120.00 |
DisclosureSEC source: 0001104659-19-032741 · a4.xml · nonDerivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,686 Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 23:02 UTC |
Williams Leslie J.Director
|
GrantStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0001104659-19-016898 · a4.xml · derivative · entry 1 Williams Leslie J. · CIK 0001770465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2029-03-19 F1 · derivative.exercise_date: Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 18:20 UTC |
Goldstein Michael H.Chief Medical Officer
|
PurchaseCommon Stock | 10,000 | $4.15 | $41,500.00 |
DisclosureSEC source: 0001104659-19-015691 · a4.xml · nonDerivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,686 F1 · balance_after: Includes 2,986 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 22:20 UTC |
Heier Jeffrey S.Director
|
PurchaseCommon Stock | 24,000 | $4.15 | $99,600.00 |
DisclosureSEC source: 0001104659-19-015692 · a4.xml · nonDerivative · entry 1 Heier Jeffrey S. · CIK 0001653082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.15 to $4.16, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 16:14 UTC |
LINDSTROM RICHARD L MDDirector
|
PurchaseCommon Stock | 56,441 | $4.33 | $244,389.53 |
DisclosureSEC source: 0001104659-19-014844 · a4.xml · nonDerivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:26 UTC |
Mattessich Antony C.Director · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000889 · a4.xml · derivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:26 UTC |
Goldstein Michael H.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000887 · a4.xml · derivative · entry 1 Goldstein Michael H. · CIK 0001691259 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:29 UTC |
Bollag Daniel MSr. VP Reg. Affairs & Quality
|
GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000894 · a4.xml · derivative · entry 1 Bollag Daniel M · CIK 0001461612 · Sr. VP Reg. Affairs & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:28 UTC |
Hanley Kevin F.Sr. VP Technical Operations
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000892 · a4.xml · derivative · entry 1 Hanley Kevin F. · CIK 0001727629 · Sr. VP Technical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:28 UTC |
Sawhney AmarpreetDirector
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000891 · a4.xml · derivative · entry 1 Sawhney Amarpreet · CIK 0001614417 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 23:27 UTC |
Notman DonaldChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001104659-19-000890 · a4.xml · derivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-01-01 F1 · derivative.exercise_date: Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 13:52 UTC |
Hanley Kevin F.See Remarks
|
PurchaseCommon Stock | 10,000 | $5.50 | $55,000.00 |
DisclosureSEC source: 0001104659-18-073444 · a4.xml · nonDerivative · entry 1 Hanley Kevin F. · CIK 0001727629 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:35 UTC |
Hanley Kevin F.SEE REMARKS
|
PurchaseCommon Stock | 10,000 | $5.60 | $56,000.00 |
DisclosureSEC source: 0001104659-18-072563 · a4.xml · nonDerivative · entry 1 Hanley Kevin F. · CIK 0001727629 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 16:15 UTC |
Bollag Daniel MSee Remarks
|
PurchaseCommon Stock | 17,400 | $5.76 | $100,224.00 |
DisclosureSEC source: 0001104659-18-072100 · a4.xml · nonDerivative · entry 1 Bollag Daniel M · CIK 0001461612 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.75 to $5.79, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:30 UTC |
Mattessich Antony C.Director · President & CEO
|
PurchaseCommon Stock | 20,000 | $5.95 | $119,000.00 |
DisclosureSEC source: 0001104659-18-053039 · a4.xml · nonDerivative · entry 1 Mattessich Antony C. · CIK 0001709900 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,900 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.93 to $5.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:13 UTC |
Notman DonaldChief Financial Officer
|
PurchaseCommon Stock | 12,500 | $6.29 | $78,625.00 |
DisclosureSEC source: 0001104659-18-052308 · a4.xml · nonDerivative · entry 1 Notman Donald · CIK 0001718019 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,300 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.